Tyra Biosciences, Inc.

TYRA · Nasdaq · SIC 2834: Pharmaceutical Preparations
68
SEC Filings

Business Summary

3 Item 1A. Risk Factors 33 Item 1B. Unresolved Staff Comments 98 Item 1C. Cybersecurity 98 Item 2. Properties 100 Item 3. Legal Proceedings 100 Item 4. Mine Safety Disclosures 100 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 100 Item 6. [Reserved] 101 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 101 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 110 ...

Next Earnings

Q2 FY2026 — expected 2026-08-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTYRAdiscussed_in_filing Cybersecurity
topic_mentionTYRAdiscussed_in_filing Cybersecurity
topic_mentionTYRAdiscussed_in_filing Cybersecurity
topic_mentionTYRAdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001193125-26-085490EDGAR87K words
2025-03-272024-12-310000950170-25-046124EDGAR—
2024-03-192023-12-310000950170-24-033461EDGAR—
2023-03-222022-12-310000950170-23-009181EDGAR—
2022-03-032021-12-310000950170-22-002814EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266967EDGAR18K words
2025-08-142025-06-300000950170-25-108899EDGAR—
2025-05-082025-03-310000950170-25-066942EDGAR—
2024-11-072024-09-300000950170-24-123346EDGAR—
2024-08-072024-06-300000950170-24-092778EDGAR—
2024-05-092024-03-310000950170-24-056971EDGAR—
2023-11-072023-09-300000950170-23-060276EDGAR—
2023-08-102023-06-300000950170-23-041382EDGAR—
2023-05-042023-03-310000950170-23-017875EDGAR—
2022-11-032022-09-300000950170-22-021937EDGAR—
2022-08-042022-06-300000950170-22-014802EDGAR—
2022-05-052022-03-310000950170-22-007879EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001193125-26-140027EDGAR1K words
2026-03-040001193125-26-091880EDGAR—
2026-03-020001193125-26-085399EDGAR—
2025-12-010001193125-25-303162EDGAR—
2025-11-050001193125-25-266916EDGAR—
2025-08-220001193125-25-185553EDGAR—
2025-08-140000950170-25-108876EDGAR—
2025-06-300001193125-25-152016EDGAR—
2025-05-290001193125-25-130670EDGAR—
2025-05-080000950170-25-066924EDGAR—

68 total filings indexed. 41 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001863127
TickerTYRA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e617adfc9791e650a697ab24499c54c1e29a59b4342bce1152d54c8042b1eb27
parent: 8cd00f7d5b8bf3fd9fc1e307fdfcdbc86ea8b9ea35822dc0e0d0685a33a429ba
content hash: 6ba289c757319f604cf3b913664b71541847cfcb0bfc4c935c5bcfd8545c4e07
signed: 2026-04-13T04:47:56.676Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf